Back

Vertex Pharmaceuticals Stock Predictions

Should You Invest in this AI Marketing High-Growth Startup by April?

Invest Now & Secure Your Stake in RAD Intel

Sell

VRTX
Vertex Pharmaceuticals

Last Price:

$488.44

Seasonality Move:

7.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed Airbnb? Your Next Chance Could Be Sitting In Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Vertex Pharmaceuticals Stock Forecast

Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 29% based on the past 33 years of stock performance.
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Is Vertex Pharmaceuticals Stock Undervalued?

The current Vertex Pharmaceuticals [VRTX] share price is $485.72. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Vertex Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 29% based on the past 33 years of stock performance.

Vertex Pharmaceuticals Stock Rating

Sell

Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals overpriced?

Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

Vertex Pharmaceuticals Stock Price History

Is VRTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

S&P500

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

vrtx.com

52-Week Data

52-Week High:

519.88

52-Week Low:

377.85

Prediction Charts

Market Cap:

124.7B

Price in USD:

485.72

Volume:

1.3M

Beta:

0.95

Technical Analysis

SMA50:

443.49

SMA100:

458.24

SMA200:

466.26

52-Wk Change:

17.94%

Stock Predictions

Is Vertex Pharmaceuticals stock public?

Yes, Vertex Pharmaceuticals is a publicly traded company.
What is the Vertex Pharmaceuticals stock quote today?

The Vertex Pharmaceuticals stock price is 485.72 USD today.
How to buy Vertex Pharmaceuticals stock online?

You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-13	454.45	462.58	465.68	450.60
Feb-14	462.50	459.00	469.55	457.36
Feb-18	455.06	462.11	467.86	451.99
Feb-19	463.12	471.76	472.12	461.91
Feb-20	474.01	480.33	481.18	472.80
Feb-21	481.36	484.24	487.38	479.69
Feb-25	480.95	480.35	486.14	476.26
Feb-26	479.93	479.10	484.98	474.24
Feb-27	475.34	474.50	486.07	473.51
Feb-28	479.90	479.79	484.98	474.01
Mar-3	477.82	483.31	490.65	477.73
Mar-4	485.49	486.22	490.70	480.11
Mar-5	485.25	491.64	495.54	483.54
Mar-6	490.15	485.72	491.62	479.78

Vertex Pharmaceuticals Earnings

Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vertex Pharmaceuticals Forecast Revenue Growth

Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.09 per share, an increase this year of $17.58 per share, and an increase next year of $2.24 per share.

* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.